Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider

Pune, May 10, 2023 (GLOBE NEWSWIRE) — “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the forecast period of 2023-2030, reaching a value of USD 28.21 billion by 2030, As per the SNS Insider research study.”

Market Overview

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, specifically the brain and spinal cord. It occurs when the immune system mistakenly attacks the protective covering of nerve fibers, known as myelin, causing inflammation and damage. The disruption of the myelin sheath and damage to nerve fibers can cause a wide range of symptoms, including vision problems, muscle weakness, fatigue, and difficulty with coordination and balance.

Market Analysis

One of the key drivers of growth of the multiple sclerosis (MS) market is the launch of new pipeline products that offer convenient oral formulations or less-frequent dosing schedules. These new products are expected to provide increased efficacy and improved patient compliance rates compared to existing treatments, which typically require more frequent administration. Furthermore, these new products may offer improved cost-effectiveness, as they may require less frequent clinic visits and less monitoring. In addition, the continued uptake of oral disease-modifying therapies (DMTs) is expected to drive market growth. These therapies are typically more expensive than other treatments, but they offer significant benefits in terms of compliance rates and convenience. As patients become more aware of these benefits, the demand for oral DMTs is likely to increase.

Get a Sample Report of Multiple Sclerosis (MS) Market@ https://www.snsinsider.com/sample-request/2706

Key Company Profiles Listed in this Report are:

The major key players are Johnson & Johnson, Biogen, Teva Neuroscience, Inc., Genentech, Inc., Dr. Reddy’s, Zydus Cadila, Berlex, Sanofi, Novartis AG, Merck KGaA, Others

Impact of Recession

A recession can have both direct and indirect effects on the multiple sclerosis (MS) market, affecting the demand for MS drugs, the healthcare priorities and preferences of patients, and the research and development of MS treatments. Healthcare providers and pharmaceutical companies need to be aware of these effects and devise strategies to mitigate the impact of economic downturns on the MS market.

Multiple Sclerosis (MS) Market Report Scope:

Key Regional Developments

North America is home to some of the world’s leading pharmaceutical companies that are actively engaged in the development and commercialization of new therapies for MS. These companies are investing heavily in research and development to bring new and innovative treatments to market. The growing demand for personalized medicine is also driving the growth of the multiple sclerosis (MS) market in North America. Personalized medicine involves tailoring treatments to the individual characteristics of the patient, including their genetic makeup, lifestyle, and environment. This approach is gaining popularity as it is believed to be more effective than a one-size-fits-all approach.

Ask for a Customization study about Multiple Sclerosis (MS) Market or Enquiry About Report@ https://www.snsinsider.com/enquiry/2706

Key Takeaway from Multiple Sclerosis (MS) Market Study

• The Disease Modifying Drugs (DMDs) segment is expected to dominate the market in the coming years, driven by factors such as increasing awareness and diagnosis of the disease, the development of new drugs, and the increasing number of approved indications for existing treatments.
• Relapsing-remitting MS (RRMS) is set to dominate the market due to its prevalence, earlier diagnosis, and the availability of effective disease-modifying therapies. While significant progress has been made in the treatment of MS, there is still much work to be done to address the unmet needs of patients with progressive forms of the disease.

Recent Developments Related to Multiple Sclerosis (MS) Market

• TASCENSO ODT® (fingolimod), a new drug for the treatment of multiple sclerosis (MS), has been launched in the United States. MS is a chronic autoimmune disease that affects the central nervous system and can cause a range of symptoms such as fatigue, muscle weakness, and difficulty with coordination and balance.
• Brainomix, a medical technology company, and Pixyl, an innovative healthcare solutions provider, have joined forces to offer a cutting-edge solution for multiple sclerosis (MS) patients. This collaboration combines Brainomix’s AI-powered software with Pixyl’s expertise in healthcare solutions to provide a comprehensive MS solution.

Table of Contents

1. Introduction

2. Research Methodology

3. Market Dynamics

4. Impact Analysis

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Global Multiple Sclerosis (MS) Market Segmentation By Drug Class

9. Global Multiple Sclerosis (MS) Market Segmentation By Disease Type

10. Global Multiple Sclerosis (MS) Market Segmentation By Mode of Administration

11. Global Multiple Sclerosis (MS) Market Segmentation By Distribution Channel

12. Regional Analysis

13. Company Profile

14. Competitive Landscape

15. Used Cases and Best Practices

16. Conclusion

Buy Single-User PDF of Multiple Sclerosis (MS) Market Report@ https://www.snsinsider.com/checkout/2706

[For more information or need any customization related to this research, mail us at info@snsinsider.com]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominate the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Access Complete Report Details@ https://www.snsinsider.com/reports/multiple-sclerosis-market-2706